Fibrinolytic therapy with tPA failed because it was based on a flawed concept
Open Access
- 16 June 2020
- journal article
- Published by Heighten Science Publications Corporation in Journal of Cardiology and Cardiovascular Medicine
- Vol. 5 (2), 131-135
- https://doi.org/10.29328/journal.jccm.1001099
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- New recombinant glycosylated prourokinase for treatment of patients with acute myocardial infarctionJournal of Invasive Cardiology, 1994
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionThe New England Journal of Medicine, 1993
- Pro‐urokinase and prekallikrein are both associated with plateletsFEBS Letters, 1993
- Fragment E-2 from fibrin substantially enhances pro-urokinase-induced Glu-plasminogen activation. A kinetic study using the plasmin-resistant mutant pro-urokinase Ala-158-rpro-UKBiochemistry, 1992
- ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarctionThe Lancet, 1992
- A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.JCI Insight, 1991
- Determinants of infarct size in non-human primatesBasic Research in Cardiology, 1990
- MEDICAL SCIENCE GISSI-2: A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarctionThe Lancet, 1990
- Thrombolytic Therapy: Current StatusThe New England Journal of Medicine, 1988
- Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysisJBIC Journal of Biological Inorganic Chemistry, 1984